Mind Cure Health Inc

Company:
Mind Cure Health Inc
Symbol:
MCUR
Country:
Canada
Sector:
Life Sciences
Industry:
psychedelic drugs
Established:
2020
Website:
https://mindcure.com/
Company:
Mind Cure Health Inc
Symbol:
MCUR
Country:
Canada
Sector:
Life Sciences
Industry:
psychedelic drugs
Established:
2020
Website:
https://mindcure.com/
Company Brief
Mind Cure Health (CA:MCUR / US:MCURF) is a diversified life sciences company combining drug development, drug synthesis, drug manufacturing and IP development in the psychedelics space to provide investors with multiple avenues to add value.

MINDCURE has assembled a deep management team, led by CEO and President Kelsey Ramsden, twice named Canada’s female entrepreneur of the year. The Company is well-capitalized to execute on operations, having raised >CAD$25 million.

MINDCURE is currently aggressively commercializing its iSTRYM digital therapeutics platform. As a universal healthcare platform, the Company is eyeing not only broad penetration in mental health clinics (in the U.S., Canada and Europe) but also the use of iSTRYM as a platform in general healthcare.
 
https://www.youtube.com/watch?v=rRjd4EUudBE
52-Week Range:
CAD$0.21 - $1.09
Current Outstanding:
93.76 million
Warrants:
27.9 million
Options:
10.6 million
Fully Diluted:
69,767,000
Market Cap:
CAD$20 million
52-Week Range:
CAD$0.21 - $1.09
Current Outstanding:
93.76 million
Warrants:
27.9 million
Options:
10.6 million
Fully Diluted:
69,767,000
Market Cap:
CAD$20 million
Highlights
  •  Led by Kelsey Ramsden, twice Canada’s Top Female Entrepreneur, and the first female CEO of a public psychedelic drug company
  • A wealth of psychedelic drug expertise/experience among MCUR’s team of Advisors, including Hamilton Morris and Dr. Dan Engle
  • iSTRYM digital therapeutics platform officially launched in August 2021, full commercial launch in early 2022
  • MINDCURE's proprietary ibogaine synthesis is advancing toward commercial production
  • The Company's "Desire Project" targets sexual dysfunction in pre-menopausal women, with a treatment population of over 9 million in the United States alone
Related Articles

Red-Hot Sale On Psychedelic Stocks

The psychedelic drug industry continues to advance by leaps-and-bounds. But psychedelic drug stocks are well off recent highs. The sale is on!

TSI EDITOR | 2021-03-09

Latest Stories

Logo

NEW BULL MARKET ALERT

Psychedelics Have Proven Potential To Disrupt Entire Mental Healthcare Industry

Get Your Guide To “Ground Floor” Opportunity In Psychedelic Stocks Now

© 2019 - 2024 Psychedelic Stock Watch, Privacy Policy, Disclaimer
powered by structure cms™